Article ; Online: Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.
2020 Volume 81, Issue 8, Page(s) 919–941
Abstract: ... strategy to speed up the discovery of effective therapeutics against SARS-CoV-2. Moreover, drug repurposing ... that are under the preclinical studies and clinical trials have been highlighted. We anticipate ... in the development of the anti-SARS-CoV-2 agent. Progresses on the development of potential therapeutics and vaccines ...
| Abstract | Coronavirus disease-19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is one of the most contagious diseases in human history that has already affected millions of lives worldwide. To date, no vaccines or effective therapeutics have been discovered yet that may successfully treat COVID-19 patients or contain the transmission of the virus. Scientific communities across the globe responded rapidly and have been working relentlessly to develop drugs and vaccines, which may require considerable time. In this uncertainty, repurposing the existing antiviral drugs could be the best strategy to speed up the discovery of effective therapeutics against SARS-CoV-2. Moreover, drug repurposing may leave some vital information on druggable targets that could be capitalized in target-based drug discovery. Information on possible drug targets and the progress on therapeutic and vaccine development also needs to be updated. In this review, we revisited the druggable targets that may hold promise in the development of the anti-SARS-CoV-2 agent. Progresses on the development of potential therapeutics and vaccines that are under the preclinical studies and clinical trials have been highlighted. We anticipate that this review will provide valuable information that would help to accelerate the development of therapeutics and vaccines against SARS-CoV-2 infection. |
|---|---|
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-07-06 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 604587-x |
| ISSN | 1098-2299 ; 0272-4391 |
| ISSN (online) | 1098-2299 |
| ISSN | 0272-4391 |
| DOI | 10.1002/ddr.21709 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 2542: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.